1. Home
  2. FBIN vs PCVX Comparison

FBIN vs PCVX Comparison

Compare FBIN & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fortune Brands Innovations Inc.

FBIN

Fortune Brands Innovations Inc.

HOLD

Current Price

$61.02

Market Cap

6.2B

ML Signal

HOLD

Logo Vaxcyte Inc.

PCVX

Vaxcyte Inc.

HOLD

Current Price

$48.72

Market Cap

6.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FBIN
PCVX
Founded
1988
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Building Products
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
6.1B
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
FBIN
PCVX
Price
$61.02
$48.72
Analyst Decision
Buy
Strong Buy
Analyst Count
8
7
Target Price
$63.13
$105.00
AVG Volume (30 Days)
1.6M
1.1M
Earning Date
02-05-2026
02-24-2026
Dividend Yield
1.73%
N/A
EPS Growth
N/A
N/A
EPS
2.67
N/A
Revenue
$4,489,900,000.00
N/A
Revenue This Year
$0.11
N/A
Revenue Next Year
$2.21
N/A
P/E Ratio
$22.51
N/A
Revenue Growth
N/A
N/A
52 Week Low
$44.04
$27.66
52 Week High
$75.82
$93.77

Technical Indicators

Market Signals
Indicator
FBIN
PCVX
Relative Strength Index (RSI) 77.98 60.49
Support Level $58.43 $44.57
Resistance Level $51.69 $49.55
Average True Range (ATR) 2.09 2.05
MACD 0.99 0.23
Stochastic Oscillator 98.26 83.05

Price Performance

Historical Comparison
FBIN
PCVX

About FBIN Fortune Brands Innovations Inc.

Fortune Brands Innovations is a leading home and security products company that has three reportable segments. The company's $2.6 billion water segment, led by the Moen brand, sells faucets, showers, and other plumbing fixtures; the $1.4 billion outdoors segment primarily sells entry doors under the Therma-Tru brand name and Fiberon-branded patio decking; and the $700 million security segment sells locks and other security devices under the Master Lock, SentrySafe, Yale, and August brand names.

About PCVX Vaxcyte Inc.

Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.

Share on Social Networks: